855 related articles for article (PubMed ID: 11228491)
41. Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease.
Oldgren J; Siegbahn A; Grip L; Linder R; Thygesen K; Wallentin L
Thromb Haemost; 2004 Feb; 91(2):381-7. PubMed ID: 14961168
[TBL] [Abstract][Full Text] [Related]
42. Clopidogrel has no effect on D-dimer and thrombin-antithrombin III levels in patients with peripheral arterial disease undergoing peripheral percutaneous transluminal angioplasty.
Cassar K; Bachoo P; Ford I; Greaves M; Brittenden J
J Vasc Surg; 2005 Aug; 42(2):252-8. PubMed ID: 16102623
[TBL] [Abstract][Full Text] [Related]
43. Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years.
Cadroy Y; Pierrejean D; Fontan B; Sié P; Boneu B
Nouv Rev Fr Hematol (1978); 1992; 34(1):43-6. PubMed ID: 1523099
[TBL] [Abstract][Full Text] [Related]
44. Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activation.
Weitz IC; Israel VK; Waisman JR; Presant CA; Rochanda L; Liebman HA
Thromb Haemost; 2002 Aug; 88(2):213-20. PubMed ID: 12195692
[TBL] [Abstract][Full Text] [Related]
45. D-dimer and thrombin-antithrombin III complex levels uncorrelated with phlebographic findings in 11 total knee replacement patients.
De Prost D; Ollivier V; Vie P; Benacerraf R; Duparc J; Khoury A
Ann Biol Clin (Paris); 1990; 48(4):235-8. PubMed ID: 2193559
[TBL] [Abstract][Full Text] [Related]
46. Detection of decreased response to activated protein C during pregnancy by an endogenous thrombin potential-based assay.
Sugimura M; Kobayashi T; Kanayama N; Terao T
Semin Thromb Hemost; 1999; 25(5):497-502. PubMed ID: 10625209
[TBL] [Abstract][Full Text] [Related]
47. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
Herren T; Straub PW; Haeberli A
Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
[TBL] [Abstract][Full Text] [Related]
48. Procoagulant activity in patients with sickle cell trait.
Lawrie AS; Pizzey A; Trompeter S; Meiselman H; Mohandas N; Dumanski JP; Westerman MP
Blood Coagul Fibrinolysis; 2012 Jun; 23(4):268-70. PubMed ID: 22343687
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
[TBL] [Abstract][Full Text] [Related]
50. Measurement of markers of activated coagulation in antithrombin III deficient subjects.
Demers C; Ginsberg JS; Henderson P; Ofosu FA; Weitz JI; Blajchman MA
Thromb Haemost; 1992 May; 67(5):542-4. PubMed ID: 1519214
[TBL] [Abstract][Full Text] [Related]
51. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
[TBL] [Abstract][Full Text] [Related]
52. Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies.
Joly B; Barbay V; Borg JY; Le Cam-Duchez V
Thromb Res; 2013 Sep; 132(3):386-91. PubMed ID: 23962423
[TBL] [Abstract][Full Text] [Related]
53. Thrombophilic dimension of recurrent fetal loss in Indian patients.
Vora S; Shetty S; Ghosh K
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):581-4. PubMed ID: 18685442
[TBL] [Abstract][Full Text] [Related]
54. Activation of endothelial and coagulation systems in left ventricular assist device recipients.
John R; Panch S; Hrabe J; Wei P; Solovey A; Joyce L; Hebbel R
Ann Thorac Surg; 2009 Oct; 88(4):1171-9. PubMed ID: 19766802
[TBL] [Abstract][Full Text] [Related]
55. [Improved postoperative prevention of thrombosis in trauma surgery by dose adjusted low molecular weight heparin based on TAT and D-dimer values].
Hansen M; Mayer A; Peetz D; Hafner G; Prellwitz W; Rommens PM
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1213-7. PubMed ID: 9931839
[No Abstract] [Full Text] [Related]
56. Thrombophilia and unexplained pregnancy loss in Indian patients.
Vora S; Shetty S; Salvi V; Satoskar P; Ghosh K
Natl Med J India; 2008; 21(3):116-9. PubMed ID: 19004141
[TBL] [Abstract][Full Text] [Related]
57. Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis.
Gschwandtner ME; Eichinger S; Hütter D; Korninger L; Lechner K; Panzer S; Pabinger I
Blood Coagul Fibrinolysis; 1996 Apr; 7(3):325-30. PubMed ID: 8735139
[TBL] [Abstract][Full Text] [Related]
58. Elevated markers of thrombin generation and fibrinolysis in patients with active and quiescent ulcerative colitis.
Zezos P; Papaioannou G; Nikolaidis N; Patsiaoura K; Vassiliadis T; Mpoumponaris A; Giouleme O; Evgenidis N
Med Sci Monit; 2009 Nov; 15(11):CR563-72. PubMed ID: 19865055
[TBL] [Abstract][Full Text] [Related]
59. Activated coagulation during open and endovascular abdominal aortic aneurysm repair.
Englberger L; Savolainen H; Jandus P; Widmer M; Do do D; Haeberli A; Baumgartner I; Carrel TP; Schmidli J
J Vasc Surg; 2006 Jun; 43(6):1124-9. PubMed ID: 16765226
[TBL] [Abstract][Full Text] [Related]
60. Subclinical haemostatic activation and current surgeon volume predict bleeding with open radical retropubic prostatectomy.
Tagawa ST; Dorff TB; Rochanda L; Ye W; Boyle S; Raghavan D; Lieskovsky G; Skinner DG; Quinn DI; Liebman HA
BJU Int; 2008 Nov; 102(9):1086-91. PubMed ID: 18671791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
